Training

Structured training in deal accounting for life sciences teams

Structured learning from half a day to two days, depending on scope: full workshops in financial strategy and revenue recognition, or an expert-guided Applied Framework Session working through one framework against your own deal.

For finance, business development, and BD&L executives who need a working command of the accounting standards behind licensing deals, not just an overview.

Two full workshopsApplied Framework SessionsOpen enrolment or in-house
Register your interest See frameworks
Michelle Olufeso-Nwokobia
Standard-setting
IASB · FASB · Business Europe · SwissHoldings
Corporate tenure
Roche AG · CHF 60bn+ group · 12 years
Published authority
Accounting for Innovation · Revenue Recognition
Qualification
FCCA Qualified 2004 · 25+ years across pharma, oil and gas, financial services, and telecoms
Why train with MIOCONSULT

The only public course where this comes from someone who has sat on both sides of the deal

These courses sit within a wider Strategic Transaction Accounting Advisory practice covering the full transaction lifecycle. Licensing and collaboration deals are where the deepest evidence and experience sit, and where most business development, legal, and finance teams first meet the accounting consequences of a deal in the room.

Built from real deals

Case studies and decision trees drawn from live licensing negotiations, not textbook examples.

Small, interactive groups

Up to twenty participants, pre-course questionnaires, live polling, and space for your specific deal questions.

Roche-honed expertise

Delivered by the former Head of Accounting External Relations for Roche's global alliances team, and IFRS 15 co-developer.

Ways to train

Three ways to work with this

Two full workshops for teams who want structured, in-depth training, and a shorter Applied Framework Session for anyone who wants expert guidance through a single framework against their own deal, without committing to a full workshop.

The in-licensing workshop builds the financial and deal-structure foundation from the in-licensing side. The revenue recognition workshop goes deep on IFRS 15 from the out-licensing side. Most teams send different people to each, some send the same person to both.

Financial Strategies for Pharma, Med-Tech & Biotech In-Licensing Deals

€2,197per person, excl. VAT · one or two days
Zoom webinar or in-house · max 20 participants · digital materials and certificate of attendance included · discounts available on request for 3 or more attendees from the same company

For Business Development, Legal, and Finance executives who need to understand the accounting consequences of an in-licensing deal before it is signed, not after. Covers financial statements, deal terms from a financial perspective, IP classification, and the accounting impact of equity transfers.

What you will learn
  • Identify the financial statements and components relevant to deal accounting
  • Understand key accounting terms and their implications in licensing contracts
  • Assess how IP classification affects deal accounting
  • Mitigate income fluctuations arising from R&D deal uncertainty
  • Evaluate the accounting implications of in-licensing deals before signature
  • Understand the accounting impact of equity transfers
Who should attend
  • Business development executives scouting and negotiating deals
  • Legal executives drafting term sheets and contracts
  • Finance executives assessing deal structures and accounting implications
  • Partnering executives sourcing complementary deals
  • R&D and marketing executives who need to explain their side of a deal to finance

Mastering Revenue Recognition for Biotech Licensing Deals

€3,400per person, excl. VAT · one or two days
Zoom webinar or in-house · max 20 participants · digital materials and certificate of attendance included · discounts available on request for 3 or more attendees from the same company

Builds on the out-licensing side. Milestone payments, tiered royalties, and multi-territory rights make traditional revenue accounting difficult, this workshop takes senior accounting and business development professionals through the full IFRS 15 five-step framework, applied to real licensing scenarios.

What you will learn
  • Apply the five-step IFRS 15 framework systematically
  • Distinguish customer relationships from collaborator relationships
  • Apply the two-part distinct criteria to pharmaceutical arrangements
  • Distinguish right-to-use from right-to-access licensing structures
  • Estimate variable consideration and apply revenue constraint principles to milestones
  • Calculate stand-alone selling prices and apply royalty recognition rules
  • Distinguish principal from agent relationships in distribution deals
  • Build documentation processes that hold up under audit
Who should attend
  • Finance directors and controllers in pharmaceutical companies
  • Revenue recognition specialists handling complex licensing deals
  • Business development managers structuring partnership agreements
  • Internal auditors reviewing revenue recognition processes
  • Legal counsel involved in licensing negotiations
Two ways to attend the workshops

Open enrolment or in-house

Open enrolment runs against fixed cohort dates, register your interest and be notified as soon as the next session is scheduled. In-house is a private session booked directly for your team.

Notify me → Book in-house →

Applied Framework Session

From $900half a day · foundation tier
Delivered via Upwork · up to 3 participants included, additional participants available · single-user framework licence included

Each MIO Consult framework is built for self-directed use. An Applied Session adds direct expert guidance: working through the framework against your own deal structure, identifying critical flags, preparing the external data the analysis needs, and producing an output ready for your board or auditor. Seven frameworks are available as individual sessions or as structured bundle programmes.

Service tiers
  • Starter, $900 · Foundation framework session: F0/F1 applied session, one framework, up to 3 participants, half a day. 5-day delivery.
  • Standard, $1,600 · Intermediate framework session: F2, F3, or IFRS 18 applied session, one framework, up to 3 participants, full day. 7-day delivery.
  • Advanced, $3,000 · Advanced or combined session: F4, F5, or a multi-framework bundle, scope confirmed after requirements review. 14-day delivery.
Good to know
  • Up to three participants from the same deal team included at no extra charge
  • Additional participants €150 each, up to six participants total
  • NDA signed before any specific deal information is exchanged

Booked and delivered through Upwork. See the frameworks page for what each framework covers before choosing a tier.

Book a session →
What past participants say

From the predecessor course, delivered via CELforPharma

Both workshops build directly on this course. These testimonials are from that earlier delivery.

“Everything for this course was great! I learned so much in 1 day, from calculating probabilities to differentiating accounts and payments. I now clearly know what to capitalise and what to expense thanks to the expert trainer Michelle.”

Tatiana Kamel, Alliance Project Leader, Servier, Russia

“The course improved my perspective from an accounting view point for the next time I negotiate an agreement. I had a much better understanding of the accounting implications of licensing deals. A very good course that worked well in a virtual setting.”

Tero Wennberg, Business Development Director, LEO Pharma, Denmark

“A very well run, interactive course with just the right level of detail for Business Development people.”

Chloe Anderson, Global Alliance Officer, Kyowa Kirin International, United Kingdom

“Trusted professionals with deep knowledge of accounting. MIO Consult GmbH was able to explain complex matters in an easy way to understand. They delivered the message very clear and concise.”

Karina C, Senior Financial Analyst, Switzerland

“Michelle gave a nice explanation of financial statements and their impact on the licensing deals and an interesting insight into materiality thresholds, with great opportunities to exchange work experience with other professionals.”

Federica Fontani, Corporate Alliance Manager, Italy

“I really enjoyed the varied content and practical examples to reinforce theory. The pre-reading sent before the course was useful, and the online format worked really well.”

Lois Paton, Business Development Manager, Kyowa Kirin, United Kingdom

“I would definitely recommend this course as it is a very good BD pharma course for someone who wants to understand better the accounting treatment.”

Marco Zevenboom, VP Finance Accounting & Reporting, Ferring, Switzerland

“Michelle is an extraordinarily knowledgeable instructor who takes care to address the key concerns each participant brings to her course. I highly recommend her course to anyone grappling with the accounting implications of BD&L deals.”

Ryan Rickards, Finance Manager Controlling, Boehringer Ingelheim, United States

“This was a very interesting course and I learned a lot. Michelle is a very skilled trainer.”

Frerich de Vries, Global Head Business Development and Licensing, Animal Health, Boehringer Ingelheim, Germany

“High quality course that met my expectations thanks to the quality of the lecturer as well as the prepared course materials and the good organisation. A perfect base to start learning more about licence and cooperation deals.”

Marie Kučerová, Head of Finance, Tax, Accounting, Sotio, Czech Republic
Prefer self-directed tools?

See the frameworks instead

Checklists, a working cash flow model, and the complete deal accounting review pack, for teams who want to work through the material themselves.

See frameworks →